Total Payments
$1.1M
2024 Payments
$3,572
Companies
53
Transactions
2,335
Medicare Patients
5,001
Medicare Billing
$1.8M
Payment Breakdown by Category
Other$822,916 (75.2%)
Travel$128,989 (11.8%)
Consulting$103,520 (9.5%)
Food & Beverage$39,133 (3.6%)
Education$20.92 (0.0%)
Gifts$0.01 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $564,991 | 245 | 51.6% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $250,050 | 80 | 22.8% |
| Travel and Lodging | $128,989 | 345 | 11.8% |
| Consulting Fee | $103,520 | 33 | 9.5% |
| Food and Beverage | $39,133 | 1,618 | 3.6% |
| Honoraria | $7,875 | 5 | 0.7% |
| Education | $20.92 | 8 | 0.0% |
| Gift | $0.01 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $247,038 | 301 | $0 (2021) |
| Valeant Pharmaceuticals North America LLC | $132,127 | 117 | $0 (2017) |
| SCILEX PHARMACEUTICALS INC. | $101,607 | 106 | $0 (2024) |
| Depomed, Inc. | $100,200 | 114 | $0 (2017) |
| Collegium Pharmaceutical, Inc. | $97,105 | 198 | $0 (2023) |
| Biohaven Pharmaceuticals, Inc. | $69,667 | 94 | $0 (2021) |
| Assertio Therapeutics, Inc. | $69,242 | 106 | $0 (2020) |
| Pernix Therapeutics Holdings, Inc. | $58,425 | 102 | $0 (2018) |
| Daiichi Sankyo Inc. | $47,580 | 68 | $0 (2018) |
| Takeda Pharmaceuticals U.S.A., Inc. | $28,554 | 110 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,572 | 82 | IBSA Pharma Inc. ($1,661) |
| 2023 | $14,962 | 94 | Scilex Pharmaceuticals Inc. ($9,885) |
| 2022 | $33,167 | 137 | Scilex Pharmaceuticals Inc. ($16,547) |
| 2021 | $117,359 | 279 | Biohaven Pharmaceuticals, Inc. ($60,413) |
| 2020 | $35,241 | 230 | US WorldMeds, LLC ($11,032) |
| 2019 | $180,862 | 324 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($121,514) |
| 2018 | $266,534 | 503 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($98,377) |
| 2017 | $442,883 | 686 | Valeant Pharmaceuticals North America LLC ($132,127) |
All Payment Transactions
2,335 individual payment records from CMS Open Payments — Page 1 of 94
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $20.86 | General |
| Category: Endocrinology | ||||||
| 12/16/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $30.27 | General |
| Category: Neuroscience | ||||||
| 12/16/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $3.44 | General |
| Category: Neuroscience | ||||||
| 12/13/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: Analgesic | ||||||
| 12/02/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $26.46 | General |
| Category: PAIN | ||||||
| 11/28/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: PAIN | ||||||
| 11/22/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: Analgesic | ||||||
| 11/18/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $24.43 | General |
| 11/15/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: Analgesic | ||||||
| 11/08/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $24.92 | General |
| Category: Endocrinology | ||||||
| 11/08/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $24.78 | General |
| Category: Neuroscience | ||||||
| 11/08/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $2.81 | General |
| Category: Neuroscience | ||||||
| 11/04/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $24.86 | General |
| Category: PAIN | ||||||
| 11/01/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: NEUROSCIENCE | ||||||
| 10/28/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $32.80 | General |
| Category: Endocrinology | ||||||
| 10/22/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $24.34 | General |
| 10/11/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: Analgesic | ||||||
| 10/07/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $25.00 | General |
| Category: Endocrinology | ||||||
| 10/03/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: PAIN | ||||||
| 09/26/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $25.71 | General |
| Category: Neuromodulation | ||||||
| 09/24/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $27.02 | General |
| Category: NEUROSCIENCE | ||||||
| 09/23/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $31.90 | General |
| Category: NEUROSCIENCE | ||||||
| 09/20/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $24.78 | General |
| Category: Neuroscience | ||||||
| 09/20/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $2.82 | General |
| Category: Neuroscience | ||||||
| 09/16/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: Analgesic | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 941 | 3,696 | $1.7M | $377,166 |
| 2022 | 19 | 1,231 | 4,154 | $2.0M | $396,583 |
| 2021 | 21 | 1,808 | 6,434 | $3.3M | $629,056 |
| 2020 | 17 | 1,021 | 4,183 | $1.7M | $405,578 |
Total Patients
5,001
Total Services
18,467
Medicare Billing
$1.8M
Procedure Codes
84
All Medicare Procedures & Services
84 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 173 | 2,174 | $869,600 | $239,581 | 27.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 76 | 241 | $96,400 | $24,025 | 24.9% |
| 64445 | Injection of anesthetic agent and/or steroid into lower back and leg nerve (sciatic nerve) | Office | 2023 | 49 | 124 | $148,800 | $17,917 | 12.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 81 | 106 | $53,000 | $16,357 | 30.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 71 | 145 | $43,500 | $11,288 | 25.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 69 | 74 | $37,000 | $10,752 | 29.1% |
| 64420 | Injection of anesthetic agent and/or steroid into rib nerve | Office | 2023 | 35 | 95 | $47,500 | $8,163 | 17.2% |
| 64450 | Injection of anesthetic agent and/or steroid into other nerve or branch | Office | 2023 | 41 | 98 | $73,500 | $6,475 | 8.8% |
| 64447 | Injection of anesthetic agent and/or steroid into thigh nerve (femoral nerve) | Office | 2023 | 38 | 63 | $47,250 | $6,437 | 13.6% |
| 64418 | Injection of anesthetic agent and/or steroid into suprascapular shoulder nerve | Office | 2023 | 32 | 78 | $44,600 | $5,951 | 13.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 53 | 81 | $24,300 | $5,369 | 22.1% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 46 | 91 | $36,400 | $5,128 | 14.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 24 | 24 | $14,400 | $4,490 | 31.2% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 38 | 75 | $37,500 | $4,021 | 10.7% |
| 64405 | Injection of anesthetic agent and/or steroid into upper neck and back of head nerve | Office | 2023 | 20 | 47 | $45,825 | $3,024 | 6.6% |
| 64425 | Injection of anesthetic agent and/or steroid into lower abdomen and groin nerve | Office | 2023 | 19 | 28 | $31,500 | $2,779 | 8.8% |
| 64421 | Injection of anesthetic agent and/or steroid into multiple rib nerves for regional nerve block | Office | 2023 | 35 | 95 | $76,000 | $2,708 | 3.6% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2023 | 25 | 38 | $15,200 | $1,760 | 11.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 16 | 19 | $3,800 | $941.45 | 24.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 207 | 2,056 | $822,400 | $213,006 | 25.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 124 | 403 | $161,200 | $34,917 | 21.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 115 | 160 | $80,000 | $23,437 | 29.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 98 | 100 | $50,050 | $16,759 | 33.5% |
| 64445 | Injection of anesthetic agent and/or steroid into lower back and leg nerve | Office | 2022 | 61 | 139 | $166,800 | $16,171 | 9.7% |
| 64420 | Injection of anesthetic agent and/or steroid into rib nerve | Office | 2022 | 41 | 109 | $54,500 | $9,535 | 17.5% |
About Dr. Gerald Sacks, M.D
Dr. Gerald Sacks, M.D is a Pain Medicine healthcare provider based in Santa Monica, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1205906781.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gerald Sacks, M.D has received a total of $1.1M in payments from pharmaceutical and medical device companies, with $3,572 received in 2024. These payments were reported across 2,335 transactions from 53 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($564,991).
As a Medicare-enrolled provider, Sacks has provided services to 5,001 Medicare beneficiaries, totaling 18,467 services with total Medicare billing of $1.8M. Data is available for 4 years (2020–2023), covering 84 distinct procedure/service records.
Ad
Practice Information
- Specialty Pain Medicine
- Location Santa Monica, CA
- Active Since 11/09/2006
- Last Updated 03/17/2018
- Taxonomy Code 207LP2900X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1205906781
Products in Payments
- RELISTOR (Drug) $300,198
- Xtampza ER (Drug) $90,498
- Gralise (Drug) $90,112
- NURTEC ODT (Drug) $80,680
- LUCEMYRA (Drug) $69,715
- Nucynta (Drug) $64,722
- ZTLido (Drug) $64,358
- ZOHYDRO ER (Drug) $57,618
- Movantik (Drug) $47,895
- Lazanda (Drug) $37,678
- ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH (Drug) $37,064
- Amitiza (Drug) $34,610
- EMBEDA (Drug) $14,963
- BUTRANS (Drug) $12,000
- Lucemyra (Drug) $9,982
- Licart (Drug) $9,382
- XIFAXAN (Drug) $9,054
- Horizant (Drug) $7,323
- SYMPROIC (Drug) $7,252
- Lucemyra/Lofexidine (Drug) $5,909
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pain Medicine Doctors in Santa Monica
Timothy Davis, M.d, M.D
Pain Medicine — Payments: $264,127
Pain Medicine $264,127
Dr. Irene Wu, M.d, M.D
Pain Medicine — Payments: $14,407
Pain Medicine $14,407
Eric Hsu, Md, MD
Pain Medicine — Payments: $13,552
Pain Medicine $13,552
Dr. Moshe Ben-Roohi, M.d, M.D
Pain Medicine — Payments: $2,746
Pain Medicine $2,746
Dr. Arash Lavian, Md, MD
Pain Medicine — Payments: $896.38
Pain Medicine $896.38
Grace Chang, Md, MD
Pain Medicine — Payments: $649.29
Pain Medicine $649.29